32 research outputs found
Conhecimento sobre hipertensão arterial e fatores associados à não adesão à farmacoterapia
OBJECTIVES: to identify the degree of knowledge of people with hypertension concerning the disease and to verify the factors associated with the non-adherence to anti-hypertensive drug therapy. METHOD: Cross sectional study, involving 422 people. Data collection took place at their homes, between December 2011 and March 2012, through interviews using the following instruments: Medication Adherence Questionnaire (MAQ-Q), Medication Regimen Complexity Index (MRCI) and a guide with questions related to sociodemographic profile, satisfaction with healthcare service and knowledge about the disease. RESULTS: 42.6% did not adhere to the drug therapy and 17.7% had poor knowledge about the disease. Factors associated with the non-adherence were: complex drug therapy, poor knowledge about the disease and dissatisfaction with the healthcare service. CONCLUSION: The findings reinforce that the complex drug therapy prescriptions, little knowledge about the disease and dissatisfaction with the healthcare service have influence on the process of non-adherence to anti-hypertensive drug therapy.OBJETIVOS: identificar el nivel de conocimiento de personas con hipertensión arterial acerca de la enfermedad y verificar los factores asociados a la no adhesión a la farmacoterapia antihipertensiva. MÉTODO: estudio transversal realizado en 422 individuos. Los datos fueron recolectados en los domicilios, entre diciembre de 2011 y marzo de 2012, por medio de entrevistas utilizando los instrumentos: Cuestionario de Adhesión a Medicamentos (CAM-Q), Índice de Complejidad de la Farmacoterapia y un guión con preguntas relativas al perfil sociodemográfico, satisfacción con el servicio de salud y conocimiento sobre la enfermedad. RESULTADOS: 42,6% no adherían a la farmacoterapia y 17,7% poseían conocimiento insatisfactorio sobre la enfermedad. Los factores asociados a la no adhesión fueron: farmacoterapia compleja, conocimiento insatisfactorio sobre la enfermedad e insatisfacción con el servicio de salud. CONCLUSIÓN: Los hallazgos refuerzan que prescripciones farmacológicas complejas, poco conocimiento sobre la enfermedad e insatisfacción con el servicio de salud influyen en el proceso de la no adhesión al tratamiento medicamentoso antihipertensivo.OBJETIVOS: identificar o nível de conhecimento de pessoas com hipertensão arterial acerca da doença e verificar os fatores associados à não adesão à farmacoterapia anti-hipertensiva. MÉTODO: estudo transversal, realizado com 422 indivíduos. Os dados foram coletados nos domicílios, entre dezembro de 2011 e março de 2012, por meio de entrevistas, utilizando os instrumentos: Questionário de Adesão a Medicamentos, Índice de Complexidade da Farmacoterapia e um roteiro com questões relativas ao perfil sociodemográfico, satisfação com o serviço de saúde e conhecimento sobre a doença. RESULTADOS: 42,6% não aderiram à farmacoterapia e 17,7% possuíam conhecimento insatisfatório sobre a doença. Os fatores associados à não adesão foram: farmacoterapia complexa, conhecimento insatisfatório sobre a doença e insatisfação com o serviço de saúde. CONCLUSÃO: os achados reforçam que prescrições farmacológicas complexas, pouco conhecimento sobre a doença e insatisfação com o serviço de saúde influenciam no processo de não adesão ao tratamento medicamentoso anti-hipertensivo
Drug-drug interactions and adverse drug reactions in polypharmacy among older adults: an integrative review
The rising tide of polypharmacy and drug-drug interactions:population database analysis 1995-2010
Background: The escalating use of prescribed drugs has increasingly raised concerns about polypharmacy. This study aims to examine changes in rates of polypharmacy and potentially serious drug-drug interactions in a stable geographical population between 1995 and 2010. Methods: This is a repeated cross-sectional analysis of community-dispensed prescribing data for all 310,000 adults resident in the Tayside region of Scotland in 1995 and 2010. The number of drug classes dispensed and the number of potentially serious drug-drug interactions (DDIs) in the previous 84 days were calculated, and age-sex standardised rates in 1995 and 2010 compared. Patient characteristics associated with receipt of ≥10 drugs and with the presence of one or more DDIs were examined using multilevel logistic regression to account for clustering of patients within primary care practices. Results: Between 1995 and 2010, the proportion of adults dispensed ≥5 drugs doubled to 20.8%, and the proportion dispensed ≥10 tripled to 5.8%. Receipt of ≥10 drugs was strongly associated with increasing age (20-29 years, 0.3%; ≥80 years, 24.0%; adjusted OR, 118.3; 95% CI, 99.5-140.7) but was also independently more common in people living in more deprived areas (adjusted OR most vs. least deprived quintile, 2.36; 95% CI, 2.22-2.51), and in people resident in a care home (adjusted OR, 2.88; 95% CI, 2.65-3.13). The proportion with potentially serious drug-drug interactions more than doubled to 13% of adults in 2010, and the number of drugs dispensed was the characteristic most strongly associated with this (10.9% if dispensed 2-4 drugs vs. 80.8% if dispensed ≥15 drugs; adjusted OR, 26.8; 95% CI 24.5-29.3). Conclusions: Drug regimens are increasingly complex and potentially harmful, and people with polypharmacy need regular review and prescribing optimisation. Research is needed to better understand the impact of multiple interacting drugs as used in real-world practice and to evaluate the effect of medicine optimisation interventions on quality of life and mortality.Publisher PDFPeer reviewe
Cost-effectiveness of insulin analogs from the perspective of the Brazilian public health system
Economic evaluation of hospital and community pharmacy services
Objective: To review the international body of literature from 2010 to 2015 concerning methods of economic evaluations used in hospital- and community-based studies of pharmacy services in publicly funded health systems worldwide, their clinical outcomes, and economic effectiveness.
Data Sources: The literature search was undertaken between May 2, 2015, and September 4, 2015. Keywords included “health economics” and “evaluation” “assessment” or “appraisal,” “methods,” “hospital” or “community” or “residential care,” “pharmacy” or “pharmacy services” and “cost minimisation analysis” or “cost utility analysis” or “cost effectiveness analysis” or “cost benefit analysis.” The databases searched included MEDLINE, PubMed, Google Scholar, Science Direct, Springer Links, and Scopus, and journals searched included PLoS One, PLoS Medicine, Nature, Health Policy, Pharmacoeconomics, The European Journal of Health Economics, Expert Review of Pharmacoeconomics and Outcomes Research, and Journal of Health Economics.
Study Selection and Data Extraction: Studies were selected on the basis of study inclusion criteria. These criteria included full-text original research articles undertaking an economic evaluation of hospital- or community-based pharmacy services in peer-reviewed scientific journals and in English, in countries with a publicly funded health system published between 2010 and 2015.
Data Synthesis: 14 articles were included in this review. Cost-utility analysis (CUA) was the most utilized measure. Cost-minimization analysis (CMA) was not used by any studies. The limited use of cost-benefit analyses (CBAs) is likely a result of technical challenges in quantifying the cost of clinical benefits, risks, and outcomes. Hospital pharmacy services provided clinical benefits including improvements in patient health outcomes and reductions in adverse medication use, and all studies were considered cost-effective due to meeting a cost-utility (per quality-adjusted life year) threshold or were cost saving. Community pharmacy services were considered cost-effective in 8 of 10 studies.
Conclusions: Economic evaluations of hospital and community pharmacy services are becoming increasingly commonplace to enable an understanding of which health care services provide value for money and to inform policy makers as to which services will be cost-effective in light of limited health care resources
The CORALIE study: improving patient education to help new users better understand their oral contraceptive
Estratégia saúde da família no tratamento de doenças crônico-degenerativas: avanços e desafios Estrategia de salud de la familia en el tratamiento de las enfermedades crónico-degenerativas: logros y retos Family health strategy in the treatment of chronic-degenerative diseases: achievements and challenges
Estudo retrospectivo, exploratório, de natureza quantitativa realizado em uma Equipe de Saúde da Família (ESF) no município de Maringá, Estado do Paraná, Brasil, com o objetivo de avaliar a efetividade da ESF no tratamento de doenças crônico-degenerativas. Foram utilizados dados do período de maio de 2006 a setembro de 2009, de 94 pacientes portadores de hipertensão arterial sistêmica e/ou diabetes mellitus, por meio da análise do sistema de acompanhamento de hipertensos e diabéticos e prontuários. Foi verificado um pequeno aumento no número de indivíduos com valores de pressão arterial (p = 0,773) e glicemia de jejum (p = 0,745) considerados adequados, no período analisado; apesar das mudanças na farmacoterapia destes pacientes e acompanhamento domiciliar. Conclui-se que apenas alterações na farmacoterapia prescrita são insuficientes para o controle adequado destas enfermidades, sendo necessário o desenvolvimento de intervenções da equipe de saúde, que promova a prática do autocuidado nos indivíduos e seus familiares.<br>Estudio retrospectivo, exploratorio, cuantitativo desarollado en un Equipo de Salud de la Familia (ESF) en la ciudad de Maringá, Paraná, Brasil, con lo objetivo de evaluar la eficacia de la ESF en el tratamiento de las enfermedades crónicas. Se utilizaron dados recogidos entre mayo de 2006 y septiembre de 2009, de 94 pacientes con hipertensión arterial y/o diabetes mellitus, mediante el análisis de los registros del sistema de control de hipertensos y diabéticos y registros. Se observó ligero incremento en el número de individuos con presión arterial (p = 0,773) y glucosa en sangre en ayunas (p = 0,745) considerados adecuados, en el periodo analizado; pesar de los cambios en la farmacoterapia y cuidados en el hogar. Se concluye que solamente cambios en la farmacoterapia no son suficientes para un adecuado control destas enfermedades, siendo necesario el desarrollo de intervenciones de la ESF, que promuevan la práctica de autocuidado en las personas y sus familias.<br>A retrospective, exploratory, quantitative study was carried in a team of heath care unit (ESF) in the municipalitie of Maringá, Paraná, Brasil, to evaluate the effectiveness of ESF in the treatment of chronic diseases. It was used data collected between May 2006 to September 2009, of 94 patients with hypertension and/or diabetes, through the analysis of the records of registration of the monitoring system of hypertensive and diabetics and charts. It was found a slight increase in the number of individual with blood pressure (p = 0.773) and fasting glucose levels (p = 0.745) considered appropriate, in the reporting period; despite changes in the pharmacotherapy of patients and home care. It was concluded that only changes in the pharmacotherapy prescribed, are insufficient for an adequate control of these diseases, being necessary the development of interventions of the health team, which promote the practice of self-care in individuals and their families